Description
Description
PT-141 (Bremelanotide) is a synthetic peptide analogue of α-melanocyte-stimulating hormone (α-MSH) studied in laboratory and clinical research. Bremelanotide acts as a melanocortin receptor agonist, with activity at multiple melanocortin receptor subtypes, including MC3R and MC4R. Research has investigated PT-141 in relation to melanocortin signaling, central nervous system pathways, and sexual-function-related biological processes.
Product configuration
- 10 mg vial: 10 mg PT-141
- Supplied as a sealed vial containing lyophilized PT-141 for laboratory and analytical research.
Research Use
This product is supplied solely for qualified laboratory research purposes. It is not intended for human or veterinary use, consumption, diagnosis, treatment, or prevention of disease.
Documentation
Batch-specific documentation, when available, may include a Certificate of Analysis (COA) and analytical testing documentation supplied by the applicable manufacturing partner.
Documentation availability may vary by product and batch.
Reviews
There are no reviews yet.